Insmed (MEX:INSM) Cyclically Adjusted FCF per Share: MXN-144.59 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:INSM Insmed Inc MEX:INSM
73 GF Score
Price MXN2,135.00
GF Value MXN3,415.35
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Insmed Cyclically Adjusted FCF per Share?

Insmed MEX:INSM +26.33% 73 Cyclically Adjusted FCF per Share is MXN-144.59 as of Jun. 2026. GuruFocus rates MEX:INSM with a GF Score™ of 73/100 and a GF Value™ of MXN3,415.35 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Insmed's adjusted free cash flow per share for the three months ended in Jun. 2026 was MXN-7.634. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN-144.59 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -9.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -11.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Insmed was 23.00% per year. The lowest was -14.10% per year. And the median was -5.10% per year.

As of today (2026-08-21), Insmed's current stock price is MXN2135.00. Insmed's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was MXN-144.59. Insmed's Cyclically Adjusted Price-to-FCF of today is .


Insmed  (MEX:INSM) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Insmed Cyclically Adjusted FCF per Share Related Terms


Insmed Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Insmed's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Insmed Cyclically Adjusted FCF per Share Chart

Insmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -56.49 -51.80 -52.18 -25.61 -85.55

Insmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.88 -65.38 -85.55 -93.59 -144.59

MEX:INSM vs INCY, BNTX, MRNA: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Insmed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Insmed Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Insmed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Insmed's Cyclically Adjusted Price-to-FCF falls into.


MEX:INSM
73GF Score
Insmed Inc MEX:INSM
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Insmed Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Insmed's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-7.634/333.9520*333.9520
=-7.634

Current CPI (Jun. 2026) = 333.9520.

Insmed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -10.087 241.428 -13.953
201612 -19.545 241.432 -27.035
201703 -11.329 243.801 -15.518
201706 -10.659 244.955 -14.532
201709 -10.749 246.819 -14.544
201712 -12.781 246.524 -17.314
201803 -17.257 249.554 -23.093
201806 -14.784 251.989 -19.593
201809 -16.344 252.439 -21.622
201812 -19.079 251.233 -25.361
201903 -19.482 254.202 -25.594
201906 -21.283 256.143 -27.748
201909 -14.812 256.759 -19.265
201912 -12.102 256.974 -15.727
202003 -15.831 258.115 -20.482
202006 -9.037 257.797 -11.707
202009 -12.917 260.280 -16.573
202012 -13.278 260.474 -17.024
202103 -25.683 264.877 -32.381
202106 -14.338 271.696 -17.623
202109 -13.509 274.310 -16.446
202112 -14.752 278.802 -17.670
202203 -17.891 287.504 -20.781
202206 -17.696 296.311 -19.944
202209 -15.056 296.808 -16.940
202212 -15.832 296.797 -17.814
202303 -19.789 301.836 -21.895
202306 -15.913 305.109 -17.417
202309 -16.966 307.789 -18.408
202312 -15.582 306.746 -16.964
202403 -21.097 312.332 -22.557
202406 -15.363 314.175 -16.330
202409 -20.924 315.301 -22.162
202412 -23.605 315.605 -24.977
202503 -30.785 319.799 -32.147
202506 -20.794 322.561 -21.528
202509 -19.247 324.800 -19.789
202512 -22.250 324.054 -22.930
202603 -18.932 330.213 -19.146
202606 -7.634 333.952 -7.634

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN-144.59 mean?
Insmed (MEX:INSM) has a Cyclically Adjusted FCF per Share of MXN-144.59 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Insmed and its competitors.
Is Insmed's Cyclically Adjusted FCF per Share too high?
Insmed's current Cyclically Adjusted FCF per Share is MXN-144.59. Overall, Insmed has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Insmed's Cyclically Adjusted FCF per Share compare to INCY and BNTX?
Insmed's Cyclically Adjusted FCF per Share of MXN-144.59 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Insmed and its competitors. Insmed's current Cyclically Adjusted FCF per Share is MXN-144.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insmed stock overvalued right now?
Based on GuruFocus' analysis, Insmed (MEX:INSM) is currently considered Possible Value Trap. The stock's GF Value™ is MXN3,415.35, compared to a current price of MXN2,135.00 — trading 37.5% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN-144.59. Insmed's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Insmed (MEX:INSM), the current Cyclically Adjusted FCF per Share is MXN-144.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Insmed (MEX:INSM) Overvalued in 2026?

Based on GuruFocus' analysis, Insmed stock appears to be undervalued. The current stock price of MXN2,135.00 is trading 37.5% below its estimated GF Value™ of MXN3,415.35. GuruFocus considers Insmed to be Possible Value Trap.

Key valuation signals for MEX:INSM:

  • Cyclically Adjusted FCF per Share: MXN-144.59
  • GF Value™: MXN3,415.35 vs. price of MXN2,135.00 (37.5% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the MEX:INSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Insmed Business Description

Address 700 US Highway 202/206, Bridgewater, NJ, USA, 08807
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
73GF Score

Get the complete analysis for MEX:INSM

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,135.00
Price
MXN3,415.35
GF Value